112 related articles for article (PubMed ID: 1376785)
1. Regional hemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide.
Gasic S; Wagner OF; Vierhapper H; Nowotny P; Waldhäusl W
J Cardiovasc Pharmacol; 1992 Feb; 19(2):176-80. PubMed ID: 1376785
[TBL] [Abstract][Full Text] [Related]
2. Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation.
Wagner OF; Vierhapper H; Gasic S; Nowotny P; Waldhäusl W
Eur J Clin Invest; 1992 Apr; 22(4):277-82. PubMed ID: 1499643
[TBL] [Abstract][Full Text] [Related]
3. Renal and hemodynamic effects of endothelin in anesthetized dogs.
Tsuchiya K; Naruse M; Sanaka T; Naruse K; Zeng ZP; Nitta K; Demura H; Shizume K; Sugino N
Am J Hypertens; 1990 Oct; 3(10):792-5. PubMed ID: 2222945
[TBL] [Abstract][Full Text] [Related]
4. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers.
Sørensen SS; Madsen JK; Pedersen EB
Am J Physiol; 1994 Mar; 266(3 Pt 2):F411-8. PubMed ID: 8160789
[TBL] [Abstract][Full Text] [Related]
5. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology.
Rabelink TJ; Kaasjager KA; Boer P; Stroes EG; Braam B; Koomans HA
Kidney Int; 1994 Aug; 46(2):376-81. PubMed ID: 7967349
[TBL] [Abstract][Full Text] [Related]
6. Regional extraction of endothelins and conversion of big endothelin to endothelin-1 in the pig.
Hemsén A; Pernow J; Lundberg JM
Acta Physiol Scand; 1991 Mar; 141(3):325-34. PubMed ID: 1858505
[TBL] [Abstract][Full Text] [Related]
7. Effects of endothelin-1 on arterial pressure: a comparison of intravenous and intra-arterial administration in conscious rabbits.
Roberts-Thomson P; McRitchie RJ; Cain MD; Chalmers JP
Clin Exp Pharmacol Physiol; 1994 Apr; 21(4):323-7. PubMed ID: 7923900
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues.
Weitzberg E; Ahlborg G; Lundberg JM
Biochem Biophys Res Commun; 1991 Nov; 180(3):1298-303. PubMed ID: 1953780
[TBL] [Abstract][Full Text] [Related]
9. Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle.
Weitzberg E; Ahlborg G; Lundberg JM
Clin Physiol; 1993 Nov; 13(6):653-62. PubMed ID: 8119059
[TBL] [Abstract][Full Text] [Related]
10. Effects of renal arterial endothelin-1 and endogenous endothelins on regional kidney blood flow and renal antihypertensive mechanisms in anesthetized rabbits.
Weekes SR; Madden AC; Bergström G; Anderson WP; Evans RG
Kidney Blood Press Res; 2000; 23(6):366-75. PubMed ID: 11070416
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs.
Donckier JE; Hanet C; Berbinschi A; Galanti L; Robert A; Van Mechelen H; Pouleur H; Ketelslegers JM
Circulation; 1991 Dec; 84(6):2476-84. PubMed ID: 1835679
[TBL] [Abstract][Full Text] [Related]
12. Effects of endothelin-1 and sarafotoxin S6b on regional hemodynamics in the conscious dog.
Leadley RJ; Zhu JL; Goetz KL
Am J Physiol; 1991 Jun; 260(6 Pt 2):R1210-7. PubMed ID: 2058748
[TBL] [Abstract][Full Text] [Related]
13. Contribution of splanchnic and peripheral vascular tissues to the disposal of angiotensin-II and to regional conversion rates of angiotensin-I: a pilot study in humans.
Gasic S; Kleinbloesem CH; Heinz G; Waldhäusl W
J Cardiovasc Pharmacol; 1991 Apr; 17(4):615-20. PubMed ID: 1711629
[TBL] [Abstract][Full Text] [Related]
14. Effects of endothelin on renal hemodynamics and excretory functions in anesthetized dogs.
Tsuchiya K; Naruse M; Sanaka T; Naruse K; Kato Y; Zeng ZP; Nitta K; Shizume K; Demura H; Sugino N
Life Sci; 1990; 46(1):59-65. PubMed ID: 2405231
[TBL] [Abstract][Full Text] [Related]
15. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
[TBL] [Abstract][Full Text] [Related]
16. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
Wanecek M; Rudehill A; Hemsén A; Lundberg JM; Weitzberg E
Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606
[TBL] [Abstract][Full Text] [Related]
17. ET-3 is extracted by and induces potent vasoconstriction in human splanchnic and renal vasculatures.
Weitzberg E; Hemsén A; Lundberg JM; Ahlborg G
J Appl Physiol (1985); 1995 Oct; 79(4):1255-9. PubMed ID: 8567570
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of endothelin in patients with abnormal vascular reactivity. Effects of ergometric exercise and acute saline loading.
Predel HG; Meyer-Lehnert H; Bäcker A; Stelkens H; Kramer HJ
Life Sci; 1990; 47(20):1837-43. PubMed ID: 2259271
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
20. Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation.
Weitzberg E
Acta Physiol Scand Suppl; 1993; 611():1-72. PubMed ID: 8379340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
